CGM trial for diabetic emergencies withdrawn before it began

NCT ID NCT06693115

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to see if continuous glucose monitors (CGMs) could help hospital staff manage patients with diabetic ketoacidosis or hyperosmolar hyperglycemic state. Researchers planned to enroll adults in the emergency department and track how often CGMs were used, how accurate they were, and whether they improved care. However, the study was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

continuous glucose monitor (CGM) device

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERGLYCEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic ketoacidosis hyperglycemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Regions Hospital

    Saint Paul, Minnesota, 55101, United States